Moderna has submitted with the US Food items and Drug Administration for crisis use authorization for its Covid-19 vaccine for individuals ages 12 to 17, in accordance to a information release from the company.
Moderna’s Covid-19 vaccine is at the moment authorized for people today ages 18 and more mature.
Past month, Moderna launched final results from a Phase 2/3 trial of 3,732 young children ages 12 to 17 in the United States blood assessments confirmed that the vaccine produced an immune response that was equal to before results in adults. In that trial, initial observations located that none of the little ones who obtained the vaccine received ill with Covid-19 commencing 14 times following their second dose. Four of the children who acquired the placebo tested optimistic for Covid-19.
The corporation has by now submitted for young-age vaccine authorization with regulators in Canada and Europe.
Pfizer gained authorization for men and women as young as 12 to use its coronavirus vaccine on May well 10.
The other Covid-19 vaccine available for use in the United States, made by Johnson & Johnson, is now licensed for for individuals ages 18 and more mature.